Radiation Oncology Treatment Planning Software Market Report 2026

Radiation Oncology Treatment Planning Software Market Overview

• Radiation Oncology Treatment Planning Software market size has reached to $2.51 billion in 2025 • Expected to grow to $3.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Rising Cancer Rates Drive Growth In The Radiation Oncology Treatment Planning Software Market • Market Trend: Advancements In Radiation Oncology Treatment Planning Systems For Enhanced Precision And Workflow Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Radiation Oncology Treatment Planning Software Market?

Radiation oncology treatment planning software is a specialized tool that helps medical professionals design and optimize radiation therapy for cancer patients. It determines the exact dosage and delivery of radiation to target tumors while minimizing harm to healthy tissues. The software utilizes 3D models from patient imaging data to fine-tune beam angles and intensities, enhancing treatment precision and minimizing side effects. The main types of radiation oncology treatment planning software are patient information systems and treatment planning systems. Patient information systems (PIS) manage and store patient data, streamline information management, and facilitate better coordination among healthcare providers for personalized treatment. It is applicable for various therapy types such as stereotactic radiosurgery (SRS), three-dimensional conformal radiation therapy (3D CRT), brachytherapy, stereotactic body radiotherapy (SBRT), intensity modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), and others and used by several end-users, including hospitals and physician’s offices, research centers, government institutions, cancer treatment centers, and others.

What Is The Radiation Oncology Treatment Planning Software Market Growth Forecast?

The radiation oncology treatment planning software market size is expected to see strong growth in the next few years. It will grow to $3.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth of precision medicine adoption, integration of AI in clinical decision support, increasing investments in cancer care infrastructure, demand for reduced treatment side effects, expansion of advanced radiotherapy modalities. Major trends in the forecast period include AI-assisted treatment planning, 3D and adaptive radiation planning, integration with advanced imaging systems, personalized radiation therapy, workflow automation in oncology planning.

Global Radiation Oncology Treatment Planning Software Market Segmentation

1) By Type: Patient Information Systems, Treatment Planning System 2) By Therapy Type: Stereotactic Radiosurgery (SRS), Three-Dimensional Conformal Radiation Therapy (3D CRT), Brachytherapy, Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Other Therapy Types 3) By End-User: Hospitals And Physician’s Offices, Research Centers, Government Institutions, Cancer Treatment Centers, Other End-Users Subsegments: 1) By Patient Information Systems: Patient Registration Systems, Appointment Scheduling Systems, Electronic Health Records (EHR) Integration, Patient Portals, Treatment History Management 2) By Treatment Planning System: 3D Treatment Planning Software, Intensity-Modulated Radiation Therapy (IMRT) Planning, Stereotactic Body Radiation Therapy (SBRT) Planning, Adaptive Radiation Therapy Planning, Brachytherapy Planning Software, Clinical Decision Support Tools

What Is The Driver Of The Radiation Oncology Treatment Planning Software Market?

The rising cancer prevalence is expected to propel the radiation oncology treatment planning software market going forward. The increasing cancer prevalence is due to several factors, including an aging population, increased exposure to risk factors (such as tobacco use, unhealthy diets, and environmental pollutants), advancements in early detection and diagnostic technologies, and improved cancer survival rates. Radiation oncology treatment planning software utilizes imaging data to target tumors and safeguard healthy tissues precisely. It boosts treatment effectiveness and minimizes side effects by generating detailed 3D models and optimizing dose and beam angles. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there were 108,270 reported cases of skin cancer, reflecting a 3.2% increase from the 104,930 cases reported in 2023. Therefore, rising cancer prevalence is driving the growth of the radiation oncology treatment planning software industry.

Key Players In The Global Radiation Oncology Treatment Planning Software Market

Major companies operating in the radiation oncology treatment planning software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Varian Medical Systems Inc., Elekta AB, Brainlab AG, IBA Worldwide SA, Canon Medical Systems Corporation, ViewRay Inc., RaySearch Laboratories AB, Vision RT Ltd., C‑RAD, MVision AI, DOSIsoft SA, Mirada Medical Ltd., Radformation Inc, Prowess Inc, Mevion Medical Systems, Oncology Systems Limited, Spectronic Medical AB, MeVis Medical Solutions AG, Lifeline Software Inc, Sun Nuclear Corporation, Shenzhen Mindray Bio‑Medical Electronics Co Ltd.

Global Radiation Oncology Treatment Planning Software Market Trends and Insights

Major companies operating in the radiation oncology treatment planning software market are focused on developing advanced features such as centralized data management to enhance precision in targeting tumors and streamline workflow processes. Centralized data management improves efficiency by consolidating patient information, treatment data, and imaging results into a single, accessible platform, ensuring streamlined workflows and enhanced decision-making. For instance, in June 2024, Accuray Incorporated, a US-based company specializing in radiation therapy solutions, launched the Accuray Precision Treatment Planning System (TPS). This system has been approved by the Chinese National Medical Products Administration (NMPA). It efficiently creates and adjusts treatment plans, accommodating tumor size, shape, and location changes. Its real-time modifications improve precision by adjusting for shifts in tumors and healthy tissues. Integrating seamlessly with the Tomo C system, it provides precise dose control through helical imaging and radiation delivery. Its patented technology ensures the radiation dose conforms to the tumor while minimizing healthy tissue exposure.

What Are Latest Mergers And Acquisitions In The Radiation Oncology Treatment Planning Software Market?

In April 2024, GE HealthCare Technologies Inc., a US-based medical technology company, acquired MIM Software Inc. for an undisclosed amount. The acquisition bolsters GE Healthcare's focus on precision care by integrating MIM's technologies, enabling personalized treatment plans and enhancing clinical workflow efficiency. This automation addresses patient complexity, resulting in faster, more effective treatment. MIM Software Inc. is a US-based provider of radiation oncology treatment planning software.

Regional Insights

North America was the largest region in the radiation oncology treatment planning software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiation Oncology Treatment Planning Software Market?

The radiation oncology treatment planning software market consists of revenues earned by entities by providing services such as image integration, simulation and visualization, plan optimization, reporting and documentation, and patient data management. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation oncology treatment planning software market also includes sales of dose calculation engines, registration tools, and adaptive radiation therapy tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radiation Oncology Treatment Planning Software Market Report 2026?

The radiation oncology treatment planning software market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radiation oncology treatment planning software industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.